Investigation of a Case of Genotype 5a Hepatitis C Virus Transmission in a French Hemodialysis Unit Using Epidemiologic Data and Deep Sequencing

被引:7
|
作者
Aho-Glele, L. S. [1 ]
Giraudon, H. [2 ]
Astruc, K. [1 ]
Soltani, Z. [3 ]
Lefebvre, A. [1 ]
Pothier, P. [2 ]
Bour, J. B. [2 ]
Manoha, C. [2 ]
机构
[1] Ctr Hosp Univ Dijon, Serv Epidemiol & Hygiene Hosp, Dijon, France
[2] Ctr Hosp Univ Dijon, Virol Lab, Dijon, France
[3] Ctr Hosp Univ Dijon, Serv Hemodialyse, Dijon, France
关键词
HYPERVARIABLE REGION-1 SEQUENCES; PREVALENCE; INFECTION; OUTBREAK; HCV; GLYCOPROTEIN;
D O I
10.1017/ice.2015.263
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BACKROUND. Hepatitis C virus (HCV) is a major cause of chronic liver disease worldwide. A patient was recently found to be HCV seropositive during hemodialysis follow-up. OBJECTIVE. To determine whether nosocomial transmission had occurred and which viral populations were transmitted. DESIGN. HCV transmission case. SETTING. A dialysis unit in a French hospital. METHODS. Molecular and epidemiologic investigations were conducted to determine whether 2 cases were related. Risk analysis and auditing procedures were performed to determine the transmission pathway(s). RESULTS. Sequence analyses of the NS5b region revealed a 5a genotype in the newly infected patient. Epidemiologic investigations suggested that a highly viremic genotype 5a HCV-infected patient who underwent dialysis in the same unit was the source of the infection. Phylogenetic analysis of NS5b and hypervariable region-1 sequences revealed a genetically related virus (>99.9% nucleotide identity). Deep sequencing of hypervariable region-1 indicated that HCV quasispecies were found in the source whereas a single hypervariable region-1 HCV variant was found in the newly infected patient, and that this was identical to the major variant identified in the source patient. Risk analysis and auditing procedures were performed to determine the transmission pathway(s). Nosocomial patient-to-patient transmission via healthcare workers' hands was the most likely explanation. In our dialysis unit, this unique incident led to the adjustment of infection control policy. CONCLUSIONS. The data support transmission of a unique variant from a source with a high viral load and genetic diversity. This investigation also underlines the need to periodically evaluate prevention and control practices.
引用
收藏
页码:134 / 139
页数:6
相关论文
共 44 条
  • [31] Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders
    Chayama, Kazuaki
    Takahashi, Shoichi
    Toyota, Joji
    Karino, Yoshiyasu
    Ikeda, Kenji
    Ishikawa, Hiroki
    Watanabe, Hideaki
    McPhee, Fiona
    Hughes, Eric
    Kumada, Hiromitsu
    HEPATOLOGY, 2012, 55 (03) : 742 - 748
  • [32] Sequence-based in silico analysis of well studied Hepatitis C Virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds
    Prabdial-Sing, Nishi
    Puren, Adrian J.
    Bowyer, Sheila M.
    BMC IMMUNOLOGY, 2012, 13
  • [33] Hepatitis C Genotype 4 Virus Nonstructural 3 and Nonstructural 5A Resistance-associated Substitutions in a 16-year-old Adolescent Failing Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin
    Serranti, Daniele
    Indolfi, Giuseppe
    Caudai, Cinzia
    Bartolini, Elisa
    Trapani, Sandra
    Zazzi, Maurizio
    Resti, Massimo
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (04) : E72 - E74
  • [34] Sequence-based in silico analysis of well studied Hepatitis C Virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds
    Nishi Prabdial-Sing
    Adrian J Puren
    Sheila M Bowyer
    BMC Immunology, 13
  • [35] Next-Generation Sequencing of 5′ Untranslated Region of Hepatitis C Virus in Search of Minor Viral Variant in a Patient Who Revealed New Genotype While on Antiviral Treatment
    Cortes, Kamila Caraballo
    Bukowska-Osko, Iwona
    Pawelczyk, Agnieszka
    Perlejewski, Karol
    Ploski, Rafal
    Lechowicz, Urszula
    Stawinski, Piotr
    Demkow, Urszula
    Laskus, Tomasz
    Radkowski, Marek
    RESPIROLOGY, 2016, 885 : 11 - 23
  • [36] Analysis of hepatitis C NS5A resistance associated polymorphisms using ultra deep single molecule real time (SMRT) sequencing
    Bergfors, Assar
    Leenheer, Daniel
    Bergqvist, Anders
    Ameur, Adam
    Lennerstrand, Johan
    ANTIVIRAL RESEARCH, 2016, 126 : 81 - 89
  • [37] Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: A population-level tool for incidence estimation
    Montoya, Vincent
    Olmstead, Andrea D.
    Janjua, Naveed Z.
    Tang, Patrick
    Grebely, Jason
    Cook, Darrel
    Harrigan, P. Richard
    Krajden, Mel
    HEPATOLOGY, 2015, 61 (06) : 1842 - 1850
  • [38] Hepatitis C Virus Transmission at an Outpatient Hemodialysis Unit-New York, 2001-2008 (Reprinted from MMWR, vol 58, pg 189-194, 2009)
    Hallack, R.
    Johnson, G.
    Clement, E.
    Parker, M.
    Schaffzin, J.
    Wallace, B.
    Smith, P.
    Thompson, N. D.
    Patel, P. R.
    Perz, J. F.
    Magri, J.
    Jaeger, J. L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (15): : 1530 - +
  • [39] Hepatitis C virus (HCV) genotype 1 NS5A resistance-associated variants are associated with advanced liver fibrosis independently of HCV-transmission clusters
    Parczewski, M.
    Kordek, J.
    Janczewska, E.
    Pisula, A.
    Lojewski, W.
    Socha, L.
    Wawrzynowicz-Syczewska, M.
    Bociaga-Jasik, M.
    Szymczak, A.
    Cielniak, I
    Siwak, E.
    Mularska, E.
    Aksak-Was, B.
    Urbanska, A.
    Luebke, N.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (04) : 513.e1 - 513.e6
  • [40] Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing
    Thuy Nguyen
    Akhavan, Sepideh
    Caby, Fabienne
    Bonyhay, Luminita
    Larrouy, Lucile
    Gervais, Anne
    Lebray, Pascal
    Poynard, Thierry
    Calmus, Yvon
    Simon, Anne
    Valantin, Marc-Antoine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    Todesco, Eve
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 53 (01) : 80 - 83